InhaltsangabeForeword. 1. Mechanisms of Acute Myocardial Infarction; M. Ferrell, V. Fuster. 2. New Generation Thrombolytic Agents; D. Collen, H.R. Lijnen. 3. Antiplatelet Agents; H.V. Anderson, J.T. Willerson. 4. Thrombin Inhibitors; T.W. Love, D.C. Stump. 5. The Thrombolysis in Myocardial Infarction (TIMI) Trials; C.P. Cannon, C.H. McCabe, E. Braunwald. 6. The Clinical Trials of the European Cooperative Study for Recombinant Tissue-Type Plasminogen Activator; A.E.R. Arnold, D. de Bono, J. Lubsen, M.L. Simoons, F. Van de Werf, M. Verstraete. 7. The International Studies of Infarct Survival (ISIS); P.M. Ridker, C. Hennekens. 8. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Trials; R.A. Harrington, R.M. Califf. 9. Trials of Pre-Hospital Thrombolysis for Acute Myocardial Infarction: Is Sooner Necessarily Better? P.J. Kudenchuk, W.D. Weaver. 10. The Late Assessment of Thrombolytic Efficacy (LATE) Trial: Impact and Implications; D.L. Brown, E.J. Topol. 11. The Global Utilization of t-PA and Streptokinase for Occluded Coronary Arteries (GUSTO-I) Trial; C. Granger. 12. The Management of Heart Failure in the Age of Reperfusion; N.S. Kleinman. 13. Thrombolytic Therapy in Elderly Patients; M. Mooradd, R.J. Goldberg, J.M. Gore. 14. Thrombolytic Retreatment for Coronary Arterial Reocclusion; R.D. Becker. 15. Radionuclide Imaging Techniques in the Thrombolytic Era; D. Jain, F.J.Th. Wackers, B.L. Zaret. 16. Biochemical Markers of Coronary Recanalization after FibrinolyticTherapy; D.R. Abendschein. 17. Monitoring Anticoagulant Therapy in the Setting of Thrombolytic Therapy; E. Bovill, R. Tracy, C. Granger, N. Hardin. 18. Acute Coronary Syndromes: Focus on Unstable Angina; C.D. Kimmelstel. 19. Future of Coronary Thrombolysis; B.E. Sobel. Index.